Showing 71-80 of 3169 results for "".
Meaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivSpecial Considerations in Psoriasis Treatment
https://practicaldermatology.com/topics/psoriasis/special-considerations-in-psoriasis-treatment/18686/Steven R. Feldman, MD, PhD sits down with DermTube Journal Club host Joshua Zeichner, MD to talk about special treatment considerations for psoriasis. He offers tips for treating pregnant patients with psoriasis and the safety of certain topicals and biologics for this population. Dr. Feldman discusJournal Club: Efficacy of Systemics After Discontinuation
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-efficacy-of-systemics-after-discontinuation/32829/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by Naiem T. Issa, MD, PhD, to discuss an article Dr. Issa authored reviewing published literature on the efficacy of biologics as monotherapy for atopic dermatitis following discontinuation. Issa NT, Abdin R, et al.Joel Schlessinger MD Discusses Electronic Medical Records
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-discusses-electronic-medical-records/19281/Joel Schlessinger MD continues to incorporate new technologies and techniques into his growing dermatology and cosmetic surgery practice at Skin Specialists P.C. To keep up with technology growth in the medical field, Joel Schlessinger MD recently integrated the use of electronic medical records (EMDiverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyJournal Club: Biologics for Young Children
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RScientifically Speaking: Sunscreen Facts from Steven Wang, MD
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-facts-from-steven-wang-md/19862/Which sunscreen ingredients work best? How can dermatologists get patients to apply properly? And what is the role for sun protective clothing? Host Joel L. Cohen, MD talks to Steven Wang, MD, about facts and misconceptions in the science of sun protection.Scientifically Speaking: Rox Anderson, MD Talks Changing Lives Through Inventions
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-rox-anderson-md-talks-changing-lives-through-inventions/20140/Rox Anderson, MD has been at the forefront of inventions that have shaped the modern practice of dermatology. He discusses his inspirations and his desire to advance patient care. Host Joel L. Cohen, MD talks to him about his latest innovations and a recent recognition.Scientifically Speaking: Sunscreen Update from Terri Michele, MD of the FDA CDER
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-update-from-terri-michele-md-of-the-fda-cder/19853/What is the latest on sunscreen labeling? What are implications of recent serology studies? And could new screening agents come to the US market? Host Joel L. Cohen, MD talks to Terri Michele, MD, Director of the Office of Nonprescription Drugs in FDA CDER about these and other hot topics in sun proTesting for Persistent Atopic Dermatitis in Pediatric Patients
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37151/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains key considerations when testing for persistent atopic dermatitis in children.